Literature DB >> 30651350

Uric acid activates aldose reductase and the polyol pathway for endogenous fructose and fat production causing development of fatty liver in rats.

Laura G Sanchez-Lozada1, Ana Andres-Hernando2, Fernando E Garcia-Arroyo1, Christina Cicerchi2, Nanxing Li2, Masanari Kuwabara2, Carlos A Roncal-Jimenez2, Richard J Johnson2, Miguel A Lanaspa3.   

Abstract

Dietary, fructose-containing sugars have been strongly associated with the development of nonalcoholic fatty liver disease (NAFLD). Recent studies suggest that fructose also can be produced via the polyol pathway in the liver, where it may induce hepatic fat accumulation. Moreover, fructose metabolism yields uric acid, which is highly associated with NAFLD. Here, using biochemical assays, reporter gene expression, and confocal fluorescence microscopy, we investigated whether uric acid regulates aldose reductase, a key enzyme in the polyol pathway. We evaluated whether soluble uric acid regulates aldose reductase expression both in cultured hepatocytes (HepG2 cells) and in the liver of hyperuricemic rats and whether this stimulation is associated with endogenous fructose production and fat accumulation. Uric acid dose-dependently stimulated aldose reductase expression in the HepG2 cells, and this stimulation was associated with endogenous fructose production and triglyceride accumulation. This stimulatory mechanism was mediated by uric acid-induced oxidative stress and stimulation of the transcription factor nuclear factor of activated T cells 5 (NFAT5). Uric acid also amplified the effects of elevated glucose levels to stimulate hepatocyte triglyceride accumulation. Hyperuricemic rats exhibited elevated hepatic aldose reductase expression, endogenous fructose accumulation, and fat buildup that was significantly reduced by co-administration of the xanthine oxidase inhibitor allopurinol. These results suggest that uric acid generated during fructose metabolism may act as a positive feedback mechanism that stimulates endogenous fructose production by stimulating aldose reductase in the polyol pathway. Our findings suggest an amplifying mechanism whereby soft drinks rich in glucose and fructose can induce NAFLD.
© 2019 Sanchez-Lozada et al.

Entities:  

Keywords:  aldose reductase; fatty acid; fructose; liver metabolism; metabolic syndrome; polyol pathway; sorbitol; uric acid

Mesh:

Substances:

Year:  2019        PMID: 30651350      PMCID: PMC6422088          DOI: 10.1074/jbc.RA118.006158

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus.

Authors:  Vera S G Ferreira; Ricardo B Pernambuco; Edmundo P Lopes; Clarice N Morais; Marbiana C Rodrigues; Maria Juliana Arruda; Lidiane Moura E Silva; Lucio Vilar
Journal:  Arq Bras Endocrinol Metabol       Date:  2010-06

Review 2.  Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.

Authors:  Thomas Jensen; Manal F Abdelmalek; Shelby Sullivan; Kristen J Nadeau; Melanie Green; Carlos Roncal; Takahiko Nakagawa; Masanari Kuwabara; Yuka Sato; Duk-Hee Kang; Dean R Tolan; Laura G Sanchez-Lozada; Hugo R Rosen; Miguel A Lanaspa; Anna Mae Diehl; Richard J Johnson
Journal:  J Hepatol       Date:  2018-02-02       Impact factor: 25.083

3.  The xanthine oxidase-NFAT5 pathway regulates macrophage activation and TLR-induced inflammatory arthritis.

Authors:  Nam-Hoon Kim; Susanna Choi; Eun-Jin Han; Bong-Ki Hong; Soo Youn Choi; H Moo Kwon; Sue-Yun Hwang; Chul-Soo Cho; Wan-Uk Kim
Journal:  Eur J Immunol       Date:  2014-08-11       Impact factor: 5.532

4.  Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.

Authors:  S Petta; C Cammà; D Cabibi; V Di Marco; A Craxì
Journal:  Aliment Pharmacol Ther       Date:  2011-07-25       Impact factor: 8.171

5.  Aldose reductase expression is induced by hyperglycemia in diabetic nephropathy.

Authors:  A D Hodgkinson; K L Søndergaard; B Yang; D F Cross; B A Millward; A G Demaine
Journal:  Kidney Int       Date:  2001-07       Impact factor: 10.612

6.  Children with NAFLD are more sensitive to the adverse metabolic effects of fructose beverages than children without NAFLD.

Authors:  Ran Jin; Ngoc-Anh Le; Shuling Liu; Monica Farkas Epperson; Thomas R Ziegler; Jean A Welsh; Dean P Jones; Craig J McClain; Miriam B Vos
Journal:  J Clin Endocrinol Metab       Date:  2012-04-27       Impact factor: 5.958

7.  Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study.

Authors:  Youming Li; Chengfu Xu; Chaohui Yu; Lei Xu; Min Miao
Journal:  J Hepatol       Date:  2009-01-09       Impact factor: 25.083

Review 8.  Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?

Authors:  Paschalis Paschos; Vasilios G Athyros; Achilleas Tsimperidis; Anastasia Katsoula; Nikolaos Grammatikos; Olga Giouleme
Journal:  Curr Vasc Pharmacol       Date:  2018       Impact factor: 2.719

9.  Inhibition of aldose reductase activates hepatic peroxisome proliferator-activated receptor-α and ameliorates hepatosteatosis in diabetic db/db mice.

Authors:  Longxin Qiu; Jianhui Lin; Fangui Xu; Yuehong Gao; Cuilin Zhang; Ying Liu; Yu Luo; James Y Yang
Journal:  Exp Diabetes Res       Date:  2011-11-03

10.  Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome.

Authors:  Miguel A Lanaspa; Takuji Ishimoto; Nanxing Li; Christina Cicerchi; David J Orlicky; Philip Ruzycki; Philip Ruzicky; Christopher Rivard; Shinichiro Inaba; Carlos A Roncal-Jimenez; Elise S Bales; Christine P Diggle; Aruna Asipu; J Mark Petrash; Tomoki Kosugi; Shoichi Maruyama; Laura G Sanchez-Lozada; James L McManaman; David T Bonthron; Yuri Y Sautin; Richard J Johnson
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  24 in total

1.  Both hyperthermia and dehydration during physical work in the heat contribute to the risk of acute kidney injury.

Authors:  Christopher L Chapman; Blair D Johnson; Nicole T Vargas; David Hostler; Mark D Parker; Zachary J Schlader
Journal:  J Appl Physiol (1985)       Date:  2020-02-20

2.  Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update.

Authors:  Claudio Borghi; Justyna Domienik-Karłowicz; Andrzej Tykarski; Krystyna Widecka; Krzysztof J Filipiak; Miłosz J Jaguszewski; Krzysztof Narkiewicz; Giuseppe Mancia
Journal:  Cardiol J       Date:  2021-01-13       Impact factor: 2.737

Review 3.  Therapeutic implications of shared mechanisms in non-alcoholic fatty liver disease and chronic kidney disease.

Authors:  Mehmet Kanbay; Mustafa C Bulbul; Sidar Copur; Baris Afsar; Alan A Sag; Dimitrie Siriopol; Masanari Kuwabara; Silvia Badarau; Adrian Covic; Alberto Ortiz
Journal:  J Nephrol       Date:  2020-05-21       Impact factor: 3.902

Review 4.  Fructose and hepatic insulin resistance.

Authors:  Samir Softic; Kimber L Stanhope; Jeremie Boucher; Senad Divanovic; Miguel A Lanaspa; Richard J Johnson; C Ronald Kahn
Journal:  Crit Rev Clin Lab Sci       Date:  2020-01-14       Impact factor: 6.250

Review 5.  Fructose Production and Metabolism in the Kidney.

Authors:  Takahiko Nakagawa; Richard J Johnson; Ana Andres-Hernando; Carlos Roncal-Jimenez; Laura G Sanchez-Lozada; Dean R Tolan; Miguel A Lanaspa
Journal:  J Am Soc Nephrol       Date:  2020-04-06       Impact factor: 10.121

Review 6.  Endogenous fructose production: what do we know and how relevant is it?

Authors:  Ana Andres-Hernando; Richard J Johnson; Miguel A Lanaspa
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2019-07       Impact factor: 4.294

Review 7.  Association of metabolic dysfunction-associated fatty liver disease with kidney disease.

Authors:  Ting-Yao Wang; Rui-Fang Wang; Zhi-Ying Bu; Giovanni Targher; Christopher D Byrne; Dan-Qin Sun; Ming-Hua Zheng
Journal:  Nat Rev Nephrol       Date:  2022-01-10       Impact factor: 28.314

8.  Fructose and Uric Acid as Drivers of a Hyperactive Foraging Response: A Clue to Behavioral Disorders Associated with Impulsivity or Mania?

Authors:  Richard J Johnson; William L Wilson; Sondra T Bland; Miguel A Lanaspa
Journal:  Evol Hum Behav       Date:  2020-10-01       Impact factor: 4.178

Review 9.  Sirtuin deficiency and the adverse effects of fructose and uric acid synthesis.

Authors:  Bernardo Rodriguez-Iturbe; Richard J Johnson; Miguel A Lanaspa; Takahiko Nakagawa; Fernando E Garcia-Arroyo; Laura G Sánchez-Lozada
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2022-03-10       Impact factor: 3.619

Review 10.  Aldose Reductase: a cause and a potential target for the treatment of diabetic complications.

Authors:  Sapna Thakur; Sonu Kumar Gupta; Villayat Ali; Priyanka Singh; Malkhey Verma
Journal:  Arch Pharm Res       Date:  2021-07-19       Impact factor: 4.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.